New Medicare Benefits Schedule (MBS) item for percutaneous transcatheter delivery of a dual filter Cerebral Embolic Protection Device (CEP) during transcatheter aortic valve implantation (TAVI)

Effective 1 July 2022, one new MBS item (38523) will be introduced for transcatheter insertion of a dual-filter (multi-filter) CEP device when a patient is undergoing the insertion of a TAVI implant.

This change is the result of recommendations by the Medical Services Advisory Committee. These changes reflect modern clinical practice and will enable patients to receive a Medicare rebate for the new CEP device (38523) when clinically appropriate. The CEP device will reduce the number of TAVI related cerebrovascular accidents (CVA’s/stroke), therefore improving health outcomes.

PDF version Quick Reference Guide – New item for percutaneous transcatheter delivery of a dual filter CEP (Word 212 KB)
Word version Quick Reference Guide – New item for percutaneous transcatheter delivery of a dual filter CEP (Word 85 KB)